Protalix BioTherapeutics (PLX) Tops Q3 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.54 -0.02 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.56 | 52 Week High | $1.11 | |||
| Open | $2.57 | 52 Week Low | $0.41 | |||
| Day High | $2.61 | P/E | N/A | |||
| Day Low | $2.52 | EPS | $-0.29 | |||
| Volume | 144,373 | |||||
